CD4 and malignant colon neoplasm: Consistent with the flow cytometry results, the immunofluorescence results revealed that αPD-1 combined with Re-FMT treatment inhibited CD4+ T cell recruitment in colon cancer tissues while promoting CD8+ T cell infiltration (Supplementary Figures 2G-I).